MSACL 2023 Abstract

Can We Transfer Insulin-like Growth Factor 1 Reference Interval between Mass Spectrometry Assays with Different Traceability? Sally Ezra (1, 2), Tara M.L. Winstoneb (2), Singh, R. (3), Dennis J. Orton (1, 2) (1) Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada (2) Alberta Precision Laboratories, Calgary, AB, Canada (3) Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA Sally Ezra, PhD (Presenter) Alberta Precision Laboratories and University of Calgary

Presenter Bio: Dr. Sally Ezra obtained a Ph.D. in Biochemistry, Cell and Molecular Biology from the University of Toronto, focusing on the pathophysiological and molecular mechanisms of rare disease-causing mutations. Dr. Ezra received a number of competitive graduate awards including the CIHR-Cell Signaling Graduate Scholarship, Toronto Musculoskeletal Centre Scholarship, and Toronto Bone and Mineral Group Scholarship. She later received a prestigious postdoctoral award from the Natural Sciences and Engineering Research Council of Canada (NSERC) to complete a postdoctoral fellowship at Western University, where she employed mass spectrometry, proteomics and phosphoproteomics in the field of cancer immunology to develop cancer diagnostics and immunotherapies. Dr. Ezra has held faculty appointments as Teaching Stream Assistant Professor of Biochemistry at Western University. She has contributed to the scientific field through multiple first-author publications in top peer-reviewed international journals and international patents.

This abstract has been withdrawn from presentation.